カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の新型コロナウイルス感染症用経口抗ウイルス薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Oral Antiviral Medications for COVID-19 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19479）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19479
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の新型コロナウイルス感染症用経口抗ウイルス薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

新型コロナウイルス感染症用経口抗ウイルス薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の新型コロナウイルス感染症用経口抗ウイルス薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

新型コロナウイルス感染症用経口抗ウイルス薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・錠剤、カプセル

用途別セグメントは次のように区分されます。
・病院、診療所

世界の新型コロナウイルス感染症用経口抗ウイルス薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Merck、Shionogi、Frontier Biotechnologies、Simcere Pharmaceutical、Guangdong Zhongsheng

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、新型コロナウイルス感染症用経口抗ウイルス薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な新型コロナウイルス感染症用経口抗ウイルス薬メーカーの企業概要、2019年～2022年までの新型コロナウイルス感染症用経口抗ウイルス薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な新型コロナウイルス感染症用経口抗ウイルス薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別新型コロナウイルス感染症用経口抗ウイルス薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの新型コロナウイルス感染症用経口抗ウイルス薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での新型コロナウイルス感染症用経口抗ウイルス薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および新型コロナウイルス感染症用経口抗ウイルス薬の産業チェーンを掲載しています。
・第13、14、15章では、新型コロナウイルス感染症用経口抗ウイルス薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 新型コロナウイルス感染症用経口抗ウイルス薬の概要
- 種類別分析（2017年vs2021年vs2028年）：錠剤、カプセル
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所
- 世界の新型コロナウイルス感染症用経口抗ウイルス薬市場規模・予測
- 世界の新型コロナウイルス感染症用経口抗ウイルス薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Merck、Shionogi、Frontier Biotechnologies、Simcere Pharmaceutical、Guangdong Zhongsheng
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：錠剤、カプセル
・用途別分析2017年-2028年：病院、診療所
・新型コロナウイルス感染症用経口抗ウイルス薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・新型コロナウイルス感染症用経口抗ウイルス薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・新型コロナウイルス感染症用経口抗ウイルス薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・新型コロナウイルス感染症用経口抗ウイルス薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・新型コロナウイルス感染症用経口抗ウイルス薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Antiviral Medications for COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Antiviral Medications for COVID-19 market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Oral Antiviral Medications for COVID-19 global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Antiviral Medications for COVID-19 include Pfizer, Merck, Shionogi, Frontier Biotechnologies, and Simcere Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Antiviral Medications for COVID-19 market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Capsule
Market segment by Application can be divided into
Hospital
Clinics
The key market players for global Oral Antiviral Medications for COVID-19 market are listed below:
Pfizer
Merck
Shionogi
Frontier Biotechnologies
Simcere Pharmaceutical
Guangdong Zhongsheng
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Antiviral Medications for COVID-19 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Antiviral Medications for COVID-19, with price, sales, revenue and global market share of Oral Antiviral Medications for COVID-19 from 2019 to 2022.
Chapter 3, the Oral Antiviral Medications for COVID-19 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Antiviral Medications for COVID-19 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Antiviral Medications for COVID-19 market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Antiviral Medications for COVID-19.
Chapter 13, 14, and 15, to describe Oral Antiviral Medications for COVID-19 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Oral Antiviral Medications for COVID-19 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Antiviral Medications for COVID-19 Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablet
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Antiviral Medications for COVID-19 Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinics
1.4 Global Oral Antiviral Medications for COVID-19 Market Size & Forecast
1.4.1 Global Oral Antiviral Medications for COVID-19 Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Antiviral Medications for COVID-19 Sales in Volume (2017-2028)
1.4.3 Global Oral Antiviral Medications for COVID-19 Price (2017-2028)
1.5 Global Oral Antiviral Medications for COVID-19 Production Capacity Analysis
1.5.1 Global Oral Antiviral Medications for COVID-19 Total Production Capacity (2017-2028)
1.5.2 Global Oral Antiviral Medications for COVID-19 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Antiviral Medications for COVID-19 Market Drivers
1.6.2 Oral Antiviral Medications for COVID-19 Market Restraints
1.6.3 Oral Antiviral Medications for COVID-19 Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Oral Antiviral Medications for COVID-19 Product and Services
2.1.4 Pfizer Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Oral Antiviral Medications for COVID-19 Product and Services
2.2.4 Merck Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shionogi
2.3.1 Shionogi Details
2.3.2 Shionogi Major Business
2.3.3 Shionogi Oral Antiviral Medications for COVID-19 Product and Services
2.3.4 Shionogi Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Frontier Biotechnologies
2.4.1 Frontier Biotechnologies Details
2.4.2 Frontier Biotechnologies Major Business
2.4.3 Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Product and Services
2.4.4 Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Simcere Pharmaceutical
2.5.1 Simcere Pharmaceutical Details
2.5.2 Simcere Pharmaceutical Major Business
2.5.3 Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Product and Services
2.5.4 Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Guangdong Zhongsheng
2.6.1 Guangdong Zhongsheng Details
2.6.2 Guangdong Zhongsheng Major Business
2.6.3 Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Product and Services
2.6.4 Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Antiviral Medications for COVID-19 Breakdown Data by Manufacturer
3.1 Global Oral Antiviral Medications for COVID-19 Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Antiviral Medications for COVID-19 Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Antiviral Medications for COVID-19
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Antiviral Medications for COVID-19 Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Antiviral Medications for COVID-19 Manufacturer Market Share in 2021
3.5 Global Oral Antiviral Medications for COVID-19 Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Antiviral Medications for COVID-19 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Antiviral Medications for COVID-19 Market Size by Region
4.1.1 Global Oral Antiviral Medications for COVID-19 Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Antiviral Medications for COVID-19 Revenue by Region (2017-2028)
4.2 North America Oral Antiviral Medications for COVID-19 Revenue (2017-2028)
4.3 Europe Oral Antiviral Medications for COVID-19 Revenue (2017-2028)
4.4 Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue (2017-2028)
4.5 South America Oral Antiviral Medications for COVID-19 Revenue (2017-2028)
4.6 Middle East and Africa Oral Antiviral Medications for COVID-19 Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Antiviral Medications for COVID-19 Sales in Volume by Type (2017-2028)
5.2 Global Oral Antiviral Medications for COVID-19 Revenue by Type (2017-2028)
5.3 Global Oral Antiviral Medications for COVID-19 Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Antiviral Medications for COVID-19 Sales in Volume by Application (2017-2028)
6.2 Global Oral Antiviral Medications for COVID-19 Revenue by Application (2017-2028)
6.3 Global Oral Antiviral Medications for COVID-19 Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Antiviral Medications for COVID-19 Sales by Type (2017-2028)
7.2 North America Oral Antiviral Medications for COVID-19 Sales by Application (2017-2028)
7.3 North America Oral Antiviral Medications for COVID-19 Market Size by Country
7.3.1 North America Oral Antiviral Medications for COVID-19 Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Antiviral Medications for COVID-19 Sales by Type (2017-2028)
8.2 Europe Oral Antiviral Medications for COVID-19 Sales by Application (2017-2028)
8.3 Europe Oral Antiviral Medications for COVID-19 Market Size by Country
8.3.1 Europe Oral Antiviral Medications for COVID-19 Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Antiviral Medications for COVID-19 Market Size by Region
9.3.1 Asia-Pacific Oral Antiviral Medications for COVID-19 Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Antiviral Medications for COVID-19 Sales by Type (2017-2028)
10.2 South America Oral Antiviral Medications for COVID-19 Sales by Application (2017-2028)
10.3 South America Oral Antiviral Medications for COVID-19 Market Size by Country
10.3.1 South America Oral Antiviral Medications for COVID-19 Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Antiviral Medications for COVID-19 Market Size by Country
11.3.1 Middle East & Africa Oral Antiviral Medications for COVID-19 Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Antiviral Medications for COVID-19 and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Antiviral Medications for COVID-19
12.3 Oral Antiviral Medications for COVID-19 Production Process
12.4 Oral Antiviral Medications for COVID-19 Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Antiviral Medications for COVID-19 Typical Distributors
13.3 Oral Antiviral Medications for COVID-19 Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oral Antiviral Medications for COVID-19 Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Antiviral Medications for COVID-19 Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Oral Antiviral Medications for COVID-19 Product and Services
Table 6. Pfizer Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Oral Antiviral Medications for COVID-19 Product and Services
Table 10. Merck Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Shionogi Basic Information, Manufacturing Base and Competitors
Table 12. Shionogi Major Business
Table 13. Shionogi Oral Antiviral Medications for COVID-19 Product and Services
Table 14. Shionogi Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Frontier Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 16. Frontier Biotechnologies Major Business
Table 17. Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Product and Services
Table 18. Frontier Biotechnologies Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Simcere Pharmaceutical Major Business
Table 21. Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Product and Services
Table 22. Simcere Pharmaceutical Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Guangdong Zhongsheng Basic Information, Manufacturing Base and Competitors
Table 24. Guangdong Zhongsheng Major Business
Table 25. Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Product and Services
Table 26. Guangdong Zhongsheng Oral Antiviral Medications for COVID-19 Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Oral Antiviral Medications for COVID-19 Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Oral Antiviral Medications for COVID-19 Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Oral Antiviral Medications for COVID-19, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Oral Antiviral Medications for COVID-19 Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Oral Antiviral Medications for COVID-19 Production Site of Key Manufacturer
Table 32. Oral Antiviral Medications for COVID-19 New Entrant and Capacity Expansion Plans
Table 33. Oral Antiviral Medications for COVID-19 Mergers & Acquisitions in the Past Five Years
Table 34. Global Oral Antiviral Medications for COVID-19 Sales by Region (2017-2022) & (K Units)
Table 35. Global Oral Antiviral Medications for COVID-19 Sales by Region (2023-2028) & (K Units)
Table 36. Global Oral Antiviral Medications for COVID-19 Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Oral Antiviral Medications for COVID-19 Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 39. Global Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 40. Global Oral Antiviral Medications for COVID-19 Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Oral Antiviral Medications for COVID-19 Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Oral Antiviral Medications for COVID-19 Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Oral Antiviral Medications for COVID-19 Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 45. Global Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 46. Global Oral Antiviral Medications for COVID-19 Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Oral Antiviral Medications for COVID-19 Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Oral Antiviral Medications for COVID-19 Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Oral Antiviral Medications for COVID-19 Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Oral Antiviral Medications for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 51. North America Oral Antiviral Medications for COVID-19 Sales by Country (2023-2028) & (K Units)
Table 52. North America Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Oral Antiviral Medications for COVID-19 Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 55. North America Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 56. North America Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 57. North America Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 58. Europe Oral Antiviral Medications for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 59. Europe Oral Antiviral Medications for COVID-19 Sales by Country (2023-2028) & (K Units)
Table 60. Europe Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Oral Antiviral Medications for COVID-19 Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 63. Europe Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 64. Europe Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 65. Europe Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 74. South America Oral Antiviral Medications for COVID-19 Sales by Country (2017-2022) & (K Units)
Table 75. South America Oral Antiviral Medications for COVID-19 Sales by Country (2023-2028) & (K Units)
Table 76. South America Oral Antiviral Medications for COVID-19 Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Oral Antiviral Medications for COVID-19 Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 79. South America Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 80. South America Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 81. South America Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales by Application (2023-2028) & (K Units)
Table 90. Oral Antiviral Medications for COVID-19 Raw Material
Table 91. Key Manufacturers of Oral Antiviral Medications for COVID-19 Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Oral Antiviral Medications for COVID-19 Typical Distributors
Table 95. Oral Antiviral Medications for COVID-19 Typical Customers
List of Figures
Figure 1. Oral Antiviral Medications for COVID-19 Picture
Figure 2. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Type in 2021
Figure 3. Tablet
Figure 4. Capsule
Figure 5. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Global Oral Antiviral Medications for COVID-19 Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Oral Antiviral Medications for COVID-19 Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Oral Antiviral Medications for COVID-19 Sales (2017-2028) & (K Units)
Figure 11. Global Oral Antiviral Medications for COVID-19 Price (2017-2028) & (US$/Unit)
Figure 12. Global Oral Antiviral Medications for COVID-19 Production Capacity (2017-2028) & (K Units)
Figure 13. Global Oral Antiviral Medications for COVID-19 Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Oral Antiviral Medications for COVID-19 Market Drivers
Figure 15. Oral Antiviral Medications for COVID-19 Market Restraints
Figure 16. Oral Antiviral Medications for COVID-19 Market Trends
Figure 17. Global Oral Antiviral Medications for COVID-19 Sales Market Share by Manufacturer in 2021
Figure 18. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Manufacturer in 2021
Figure 19. Oral Antiviral Medications for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Oral Antiviral Medications for COVID-19 Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Oral Antiviral Medications for COVID-19 Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Oral Antiviral Medications for COVID-19 Sales Market Share by Region (2017-2028)
Figure 23. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Region (2017-2028)
Figure 24. North America Oral Antiviral Medications for COVID-19 Revenue (2017-2028) & (USD Million)
Figure 25. Europe Oral Antiviral Medications for COVID-19 Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue (2017-2028) & (USD Million)
Figure 27. South America Oral Antiviral Medications for COVID-19 Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue (2017-2028) & (USD Million)
Figure 29. Global Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2017-2028)
Figure 30. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Type (2017-2028)
Figure 31. Global Oral Antiviral Medications for COVID-19 Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 33. Global Oral Antiviral Medications for COVID-19 Revenue Market Share by Application (2017-2028)
Figure 34. Global Oral Antiviral Medications for COVID-19 Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2017-2028)
Figure 36. North America Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 37. North America Oral Antiviral Medications for COVID-19 Sales Market Share by Country (2017-2028)
Figure 38. North America Oral Antiviral Medications for COVID-19 Revenue Market Share by Country (2017-2028)
Figure 39. United States Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2017-2028)
Figure 43. Europe Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 44. Europe Oral Antiviral Medications for COVID-19 Sales Market Share by Country (2017-2028)
Figure 45. Europe Oral Antiviral Medications for COVID-19 Revenue Market Share by Country (2017-2028)
Figure 46. Germany Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Oral Antiviral Medications for COVID-19 Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Oral Antiviral Medications for COVID-19 Revenue Market Share by Region (2017-2028)
Figure 55. China Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2017-2028)
Figure 62. South America Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 63. South America Oral Antiviral Medications for COVID-19 Sales Market Share by Country (2017-2028)
Figure 64. South America Oral Antiviral Medications for COVID-19 Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Oral Antiviral Medications for COVID-19 Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Oral Antiviral Medications for COVID-19 Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Oral Antiviral Medications for COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Oral Antiviral Medications for COVID-19 in 2021
Figure 76. Manufacturing Process Analysis of Oral Antiviral Medications for COVID-19
Figure 77. Oral Antiviral Medications for COVID-19 Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）
  • 関節炎処方薬のグローバル市場展望 2023年-2029年：経口投与、局所投与
  • 世界のOTC鎮痛剤市場2022年：市場規模予測（～2028年）
  • 世界の抗ウイルス＆抗菌コーティング市場2022年：市場規模予測（～2028年）
  • 副鼻腔炎治療薬のグローバル市場展望 2023年-2029年：抗生物質、コルチコステロイド、鼻詰まり除去剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19479 )"世界の新型コロナウイルス感染症用経口抗ウイルス薬市場2022年：市場規模予測（～2028年）" (英文：Global Oral Antiviral Medications for COVID-19 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。